Back to News
Market Impact: 0.28
BioStem Secures Up To $40 Mln Committed Equity Facility
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsPrivate Markets & Venture
BioStem Technologies entered into a $40 million committed equity facility with Roth Principal Investments, an affiliate of Roth Capital Partners. The financing provides potential capital to support the regenerative-medicine company and its perinatal tissue allograft products, though the article does not specify drawdown timing or use of proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AI Inference Startup Fal Raises Capital at $16 Billion Valuation
- Berkshire-owned utility’s wildfire lawsuits head to Oregon Supreme Court